Skip to main content
U.S. flag

An official website of the United States government

U.S. Department of Health & Human Services | National Institutes of Health

Retirement Symposium for Carter Van Waes Set for May 13

Event Date: May 13, 2022
Time: 9:30 AM - 4:15 PM ET
Location: Virtual. Limited in-person attendance is open to NIH staff only; RSVP required.

April 21, 2022

Dr. Carter Van Waes

On Friday, May 13, 2022, the National Institute on Deafness and Other Communication Disorders (NIDCD) will hold a symposium honoring Carter Van Waes, M.D., Ph.D., clinical director of the NIDCD and chief of the NIDCD Head and Neck Surgery Branch, Tumor Biology Section. The day-long symposium will highlight the impact Dr. Van Waes has had on the NIDCD clinical program and the critical contributions he has made to head and neck cancer research. Dr. Van Waes will retire in July.

The virtual symposium will be open to all. Live captioning will be available. Limited in-person attendance (RSVP required) is available for NIH staff only.

  • What: A symposium in celebration of the career of Carter Van Waes, M.D., Ph.D.
  • When: Friday, May 13, 2022, from 9:30 a.m. to 4:15 p.m.
  • Where: Virtual. (Limited in-person attendance is open to NIH staff only. RSVP required.) For questions or reasonable accommodation requests, contact Elyssa Monzack, Ph.D., NIDCD deputy scientific director.

Agenda

A Symposium Celebrating the Career of Dr. Carter Van Waes
May 13, 2022
Time Presentation
9:30 a.m.

Welcome and introduction
Debara Tucci, M.D., M.S., M.B.A.
Director, NIDCD

Lisa Cunningham, Ph.D.
Scientific Director, NIDCD
9:45-10:00 a.m.

John Sunwoo, M.D.
Stanford University
Innate Lymphoid Cells in Head and Neck Cancer
10:05-10:20 a.m.

Anil Lalwani, M.D.
Columbia University
Opening the Window for Precision Inner Ear Medicine
10:25-10:40 a.m.

Frank Ondrey, M.D., Ph.D.
University of Minnesota
A Road to Cancer Translational Chemoprevention
10:45-11:00 a.m.

Daniel Choo, M.D.
University of Cincinnati
The Confluence of Science and Surgery in the Next Era of Otology
11:05-11:20 a.m.

Break
11:20-11:35 a.m.

Zhong Chen, M.D., Ph.D.
National Institute of Dental and Craniofacial Research
A 28 Year Journey in Head and Neck Cancer Research—from NIDCD to NIDCR
11:40-11:55 a.m.

Gang Dong, M.D., Ph.D.
National Institute of Allergy and Infectious Diseases
A Head and Neck Cancer Biologist to a NIAID Program Administrator
Noon-12:15 p.m.

Michael Hoa, M.D.
NIDCD
Of Mice and Humans: Investigations into Hearing Instability Disorders
12:20-12:35 p.m.

Wade Chien, M.D.
NIDCD
Development of Gene Therapy as a Treatment for Hearing Loss and Dizziness
12:40-1:40 p.m.

Lunch (kindly provided by the Van Waes family)
1:40-1:55 p.m.

Anthony Saleh, Ph.D.
miRecule
Discovery and Development of a MicroRNA Therapeutic for the Treatment of Multi-Drug Resistant Head and Neck Cancer
2:00-2:15 p.m.

Nicole Schmitt, M.D.
Emory University
IAP Antagonists for Head and Neck Cancer
2:20-2:35 p.m.

Clint Allen, M.D.
NIDCD
Neoadjuvant Immunotherapy for HNSCC at the NIH: How CVW Helped Make it Happen
2:40-2:55 p.m.

Nyall London Jr., M.D., Ph.D.
NIDCD
Olfactory Neuroblastoma: The Surgeon-Scientist Perspective
3:00-3:15 p.m.

Andrew Griffith, M.D., Ph.D.
University of Tennessee
The Puzzle of Human Hereditary Hearing Loss: 25 Years of Finding the Pieces and Putting them Together at NIDCD
3:20-3:30 p.m.

Break
3:30-4:15 p.m.

Closing Remarks
Carter Van Waes, M.D., Ph.D.
Clinical Director, NIDCD
4:15-4:30 p.m.

Attendee questions/comments
Last Updated Date: